Joon-Seo Park
Comptroller/Controller/Auditor bij NC& CO.,LTD
Profiel
Joon-Seo Park is currently working as an Auditor at NC & Co., Ltd., Han Kyung Accounting Corp., Biobud Ltd., and Nconnect Corp.
He has a graduate degree from Seoul National University and an undergraduate degree from Sogang University.
Actieve functies van Joon-Seo Park
| Bedrijven | Functie | Begin |
|---|---|---|
| NC& CO.,LTD | Comptroller/Controller/Auditor | - |
Han Kyung Accounting Corp.
 Han Kyung Accounting Corp. Miscellaneous Commercial ServicesCommercial Services Han Kyung Accounting Corp. provides accounting, payroll, auditing, and tax consulting services. The private company is based in Seoul, South Korea. The CEO of the South Korean company is Jae-Seon Hong. | Corporate Officer/Principal | 30-09-2012 |
| Nconnect Corp. | Comptroller/Controller/Auditor | - |
Biobud Ltd.
 Biobud Ltd. Medical SpecialtiesHealth Technology Biobud Ltd. engages in the development of biopharmaceuticals for cardiovascular prevention, diagnosis and treatment. The company was founded on March 28, 2000, and is headquartered in Seongnam, South Korea. | Comptroller/Controller/Auditor | - |
Opleiding van Joon-Seo Park
| Seoul National University | Graduate Degree |
| Sogang University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NC& CO.,LTD | Electronic Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Han Kyung Accounting Corp.
Han Kyung Accounting Corp. Miscellaneous Commercial ServicesCommercial Services Han Kyung Accounting Corp. provides accounting, payroll, auditing, and tax consulting services. The private company is based in Seoul, South Korea. The CEO of the South Korean company is Jae-Seon Hong. | Commercial Services |
Biobud Ltd.
Biobud Ltd. Medical SpecialtiesHealth Technology Biobud Ltd. engages in the development of biopharmaceuticals for cardiovascular prevention, diagnosis and treatment. The company was founded on March 28, 2000, and is headquartered in Seongnam, South Korea. | Health Technology |
| Nconnect Corp. |
